Objective: Qatar is a small country on the Eastern coast of the Arabian Peninsula. Its population is a unique mixture of native citizens and immigrants. We aimed to describe the features of epilepsy in Qatar as such information is virtually lacking from the current literature. Methods: We summarized information retrospectively collected from 468 patients with epilepsy seen through the national health system adult neurology clinic. Results: Epilepsy was classified as focal in 65.5% of the cases and generalized in 23%. Common causes of epilepsy were as follows: stroke (9%), hippocampal sclerosis (7%), infections (6%), and trauma (6%). Sixty-six percent of patients were receiving a single antiepileptic drug, with levetiracetam being the most frequently prescribed drug (41% of subjects). When the patients were divided by geographical background, remote infections caused the epilepsy in 15% of Asian patients (with neurocysticercosis accounting for 10%) but only in 1% of Qatari and 3% of Middle East/North African subjects (with no reported neurocysticercosis) (p b 0.001). Cerebrovascular and neurodegenerative etiologies were the most prominent in Qataris, accounting for 14% (p = 0.005) and 4% (p = 0.03) of cases, respectively. The choice of antiepileptic drugs varied also according to the regional background, but the seizure freedom rate did not, averaging at 54% on the last clinic visit. Significance: To our knowledge, this is the first detailed information about epilepsy in Qatar. The geographical origin of patients adds to the heterogeneity of this disorder. Neurocysticercosis should be in the etiological differential diagnosis of epilepsy in patients coming from Southeast Asian countries, despite the fact that it is not endemic to Qatar. The choice of antiepileptic drugs is influenced by the availability of individual agents in the patients' native countries but had no bearing on the final seizure outcome.
Epilepsy is one of the most prevalent neurologic conditions and an important cause of disability and socioeconomic burden. It is a universal problem without national or ethnic boundaries, although its prevalence and incidence vary between low-and high-income countries. Approximately 70 million people worldwide suffer from the disorder; of which, 724,500 live in Arab countries [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . Very little is known about the epidemiology and other aspects of epilepsy in Qatar, a small country located on the Northeastern coast of the Arabian Peninsula. The country's population of just over two million represents a unique mixture of native Qataris and a large number of expats; most of whom are from other regions of the Middle East and North Africa (MENA) and Asia (Qatar Statistics Authority). Studies describing the characteristics of epilepsy in Qatar and in the larger Middle East or Arabian Peninsula are rare [10, 11] and do not address variables such as etiology of epilepsy, treatment, or outcome. These features may be influenced by the diversity within the same society, depending on socioeconomic status as well as the different ethnic and national backgrounds. Epilepsy & Behavior 63 (2016) 
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In an attempt to address these issues, we embarked on the following cross-sectional study, mining data on a sample of patients with epilepsy (PWE) seen in a centralized national health system. The latter effectively cares for almost all PWE in the country, providing a unique opportunity for epidemiological studies on epilepsy.
Methods

Patients
This project involved a retrospective chart review of PWE followed in the adult neurology clinic at Hamad Medical Corporation (HMC), the state health system that hosts the only comprehensive neurology services in the country. The clinic provides care for subjects 14 years of age and above. Almost all patients with epilepsy followed within Qatar receive medical care at HMC. Thus, data from this single institute adequately represent the state of epilepsy in the country. Patients attending these clinics between January 2014 and August 2014 had their charts reviewed after approval by the Institutional Review Board. To be retained in the study, patients must have had a clear diagnosis of epilepsy as defined by the ILAE [12] . They must have attended the clinic at least twice (to allow outcome measurement and completion of the basic diagnostic workup). Patients with a single seizure and relatively low risk of recurrence who were left untreated and discharged, patients with provoked seizures, or those with insufficient medical information for diagnosis were excluded.
The patients' demographics (age, gender, nationality) were collected, along with their employment status. We documented the age at onset of epilepsy, pertinent personal and family history, seizure type(s), epilepsy syndrome, current and previous antiepileptic drugs (AEDs) used, neuroimaging and electroencephalographic findings, and presumed cause of epilepsy and its severity (defined according to seizure freedom versus recurrence of seizures as reported at last visit). A family history for epilepsy was obtained by scrutinizing the corresponding section in the clinic note as documented from the initial clinic visit and referred to first-and second-degree relatives known to have epilepsy. All collected data were entered in a specifically designed database and subsequently analyzed.
Statistical analysis
Demographic and clinical characteristics of patients were described as mean and standard deviation for numerical variables and as frequency distribution for categorical variables. Patients were subsequently divided according to their country of origin into three subgroups: Qatari, from MENA region excluding Qatar, or Asian. Chi-squared test was used to compare demographic and clinical variables between the three groups. Patients from Europe, America, Australia, and South Africa were excluded from the subgroup comparisons because of the small sample size (n = 16). All analyses are carried out using IBM-SPSS (version 23, Armonk, NY: IBM Corp, USA). A p-value of 0.05 or less was considered statistically significant.
Despite the inclusion of the most complete records, some individual subjects still had missing information on one or more variables. We quantified the missingness for such variables and found it to be less than 3% for the epilepsy risk factors, etiology, imaging results, epilepsy classification, and outcome; at 5% for a detailed neurological exam; 6% for employment; and 7% for EEG results. In order to obtain simplified percentages that are useful for comparison with existing literature, we excluded the small amount of missing data from the calculated proportions in the Results section.
Results
Demographics
The final database contained 468 subjects. Two hundred eighty (60%) were men. Forty countries of origin were identified. One hundred eighty subjects (38%) are native Qataris, 118 (25%) were from other MENA countries, and 154 (33%) were of Southeast Asian origin. Egypt had the highest contribution to the MENA group with 24 patients, whereas India and Nepal had the highest representation in the Asian group with 63 and 30 patients, respectively. The mean age at first seizure was 25 (±17) and at last follow-up 34 (±15) years. Sixty percent of subjects were employed or attending school regularly.
Risk factors
Six percent of patients had a history of perinatal/neonatal problems, 7% had a personal history of febrile seizures, 10% had a personal history of mental retardation and/or cerebral palsy, and 16% had a family history of seizures.
Seizure types and epilepsy syndromes
Generalized tonic-clonic seizures were the most common seizure type, noted in 89% of subjects. Focal seizures with impairment of consciousness or awareness were seen in 19% of cases whereas focal seizures without such impairment were observed in 22%. Myoclonus, absence, tonic, and atonic seizures were noted in 11, 4, 2, and less than 1%, respectively.
Fifty-eight percent of subjects experienced only one type of seizure, 36% reported two types, and 6% had three or more types.
Epilepsy was classified as focal in 65.5% of cases (extratemporal in 29%, temporal in 19%, and focal without further localization in 18%) and generalized in 23% (juvenile myoclonic epilepsy (JME) in 10%, symptomatic generalized in 5%, juvenile absence epilepsy in 2%). The remaining subjects (11%) had no committed classification as either focal or generalized.
Clinical and diagnostic features
Fifteen percent of patients had an abnormal neurological exam. Electroencephalography was normal in 44.5% of subjects. It showed focal epileptiform discharges in 32%, generalized epileptiform discharges in 17%, and nonspecific changes (e.g., focal or generalized slowing) in 6%. Imaging with MRI and/or CT showed clear epileptogenic pathologies in 40% and nonspecific changes (e.g., arachnoid cysts, cerebellar atrophy) in 3% and was normal in 57% of subjects.
Etiologies
Fifty-seven percent had no identifiable cause. Vascular causes, including strokes and vascular malformations, were the most common identified etiology, accounting for 11% of cases. The relevant etiologies are shown in Fig. 1 .
Treatment and outcome
Sixty-seven percent of patients were previously tried on at least one AED other than the current treatment. Sixty-six percent of patients were currently on monotherapy, 24% were on two AEDs, and 9% were on three or more. Overall, the most commonly prescribed drug was levetiracetam (41%) followed by valproic acid (25%), carbamazepine (22%), and phenytoin (20%). On current therapy, 54% of patients were seizure-free for at least six months. The remaining 46% with recurring recent seizures included the 41% who showed a partial response (more than 50% reduction in disabling seizure frequency between the initial and last documented neurology clinic visits) and the 5% whose seizures were refractory. Table 1 summarizes the relevant demographic and clinical variables according to the region of origin. Some differences are highlighted in this paragraph. More patients from an Asian background were male or employed. As for the age at last follow-up, a greater proportion of Qatari patients were 60 years of age or older (14%) compared with MENA or Asian patients (3 and 2%, respectively).
Epilepsy features by geographical background
The incidence of a positive family history for epilepsy ranged from 12% in Asians to 21% in Qataris, a difference that reached statistical significance (p = 0.04) when these two groups were compared excluding the MENA patients who had an intermediate family history rate of 16%.
Overall, strokes accounted for 9% of epilepsy cases. Subgroup analysis showed that strokes contributed to 14% of cases in Qataris but less than 6% in MENA and Asian patients (p = 0.005). Neurodegenerative disorders, including mainly dementias of various types, accounted for 2% of epilepsy cases overall. They contributed to 4% of cases among Qataris but only 2% of MENA patients and none in the Asian subgroup (p = 0.03). Remote infections accounted for 6% of epilepsy cases overall, with 15% of cases in Asians but only 1 and 3% among Qatari and MENA subjects, respectively (p b 0.001). Neurocysticercosis (NCC) accounted for more than half of the infections seen in Asians (10% of our Asian PWE) but was absent in the other subgroups (p b 0.001). Furthermore, on additional scrutiny of the specific countries of origin for the 15 individuals with NCC, 12 came from Nepal. This represented 40% of our PWE from this single country. The remaining three patients with NCC were from India and the Philippines.
The most commonly prescribed drug among Qatari and MENA patients was levetiracetam (49 and 47%, respectively) while phenytoin was the most prescribed drug in patients of Asian origin (33%). Despite the difference in treatment choices, the seizure outcome did not vary between the subgroups. The seizure-free rate reached 48% in Qataris, 57% in MENA subjects, and 59% in Asians (p = 0.1).
Discussion and conclusion
Little is known about the epidemiology or other aspects of epilepsy in Qatar, a small country with a rich mix of ethnic backgrounds. We found only one published study on the topic of epilepsy in this country [13] . Based on data collected between 1992 and 2000, that study postulated an annual incidence of epilepsy in Qatar of 174 per 100,000 persons, a figure considerably higher than that reported in most other regions [10] . The authors did not detail the patients' characteristics and did not specify whether single and provoked seizures were included. In addition, the population of the country has quadrupled since.
In our cohort, GTC seizures were by far the most common seizure type, with epilepsy diagnosed as focal in the majority of subjects. Although there are inconsistencies in the international literature about the proportion of the different seizure types and epilepsy syndromes, most published studies suggest a larger contribution of focal epilepsy to the burden of disease, particularly in adults [6, 8, [14] [15] [16] [17] [18] [19] [20] . Focal epilepsy was more often extratemporal than temporal in our population. This differentiation was based on the clinical manifestations at seizure onset, as well as the EEG and neuroimaging data. Manford et al. reported similar findings from the United Kingdom; among 160 patients with focal epilepsy and a localizable seizure onset, more than 60% were attributed to extratemporal foci [21] . In our present series, among the generalized epilepsy syndromes, JME was the most common single entity, accounting for 10% of our cohort. In a study from Saudi Arabia, Obeid and Panayiotopoulos reported a strikingly similar proportion of 10.7% (42 out of 391 cases) from an adult epilepsy clinic (age over 15 years) [22] . The prevalence of JME in large cohorts varies between studies and has been estimated to be five to 10% of all epilepsies. As the seizures of most patients with this syndrome are easily controlled, lower prevalence is reported in highly specialized clinics because of referral bias, whereas less selective clinics like ours tend to report the higher proportion [23, 24] . The revised ILAE classification recommended abandoning terms such as idiopathic, symptomatic, and cryptogenic when describing the underlying cause [25] . Accordingly, the etiology of epilepsy was presumed genetic or unknown in 57% of our cases, a proportion that falls within the previously published range for epilepsy with unidentified causes [6, 15, [17] [18] [19] [20] . The rest of our patients had an identifiable etiology (structural/metabolic), with stroke, trauma, infections, and hippocampal sclerosis leading in this category.
Most AEDs are available in Qatar, and their cost is, in part, subsidized by the state. Levetiracetam is the most commonly prescribed AED in Qatar. This treatment trend is likely explained by the drug's broad efficacy across many seizure types, ease of dose escalation, favorable side effect profile, and reduced drug interactions [26, 27] . Not surprisingly, the more traditional AEDs (e.g., valproate, carbamazepine, phenytoin) are also commonly used.
Of particular interest are the differences we found between our patients based on their native region. Abou-Khalil et al. systematically questioned patients about family history of epilepsy and reported that 32.8% of the studied patients in the Vanderbilt Epilepsy Program in Tennessee had a positive family history (first-or second-degree relatives) of epilepsy [28] . The family history may be underreported in a retrospective study like ours, but the difference between the subgroups is worth noting. A positive family history of epilepsy was more common in our native Qatari subgroup at a rate of 21%, compared with that in 12% in our Asian patients. This finding may suggest a stronger genetic predisposition in the Qatari nationals and could be at least partially explained by the high prevalence of parental consanguinity. Consanguineous unions account for more than 50% of marriages in the State of Qatar [11, 29] , a factor that is reported to increase the risk of epilepsy in the offspring (genetic/idiopathic epilepsy in particular) [4, 9, 30] . Similarly, elevated rates of family history are also reported in PWE from neighboring Saudi Arabia [31] .
The contributing etiology varied with geographical background. Remote infections, especially NCC, were the most commonly identified cause of epilepsy in our Asian subgroup. This is consistent with the literature suggesting a high contribution of infections to epilepsy cases in developing countries in general and the specific high rate of NCC in Southeast Asia, Latin America, and sub-Saharan Africa [4, 7, 8, 16, 31] . Nearly one-third of epilepsy cases were associated with NCC in both urban and rural areas of Vellore, India [32] . Among 300 incident cases of epilepsy in Nepal, 47% were caused by NCC [33] . This is comparable with our 40% rate of NCC in immigrant PWE from Nepal, the country with the highest NCC contribution in our database. The rate of remote infections in the Qatari and MENA subjects was lower and comparable with what is reported in cohorts with epilepsy from Europe and North America [19, 20] . No NCC cases were identified in these subgroups in our study. Stroke is the most frequently identified cause of epilepsy in industrialized countries, accounting for nine to 18% of all new cases and about one-third of cases with an identified cause [6, 15, 19, 20] . Our native Qatari group parallels this finding. As the etiology of epilepsy is age-dependent [18] , it is not surprising that cerebrovascular disease was an important contributor to the burden of epilepsy in our Qatari patients, who represented the bulk of our subjects over 60. The same applies to neurodegenerative disorders.
The treatments utilized also differed, with the Qatari and MENA subjects being more likely to receive the newer AEDs. This practice could be understood through a financial and socioeconomic scope. Although most AEDs are available and subsidized by the state, the copay for the newer drugs is much higher. Many of our Asian patients are laborers on a limited income, leading to being more mindful about the cost incurred by the patient in this specific population. Also, since anticonvulsant treatment is typically chronic, the availability and affordability of the prescribed drug once the patient relocates to his native country need to be taken into account (expats are on specified term contracts). Old AEDs are globally available, whereas newer ones are less widely marketed in some Asian and developing countries, in addition to their prohibitive cost [4, 7, 8, 31, [33] [34] [35] [36] [37] . Despite the difference in treatment choices, the seizure outcome did not vary significantly between the subgroups. The rate of seizure freedom at the last follow-up was 54%. This proportion is hard to compare with published data on seizure remission because of major methodological differences; long-term remission is achieved in 60-85% in most published longitudinal cohort studies [38] [39] [40] [41] . Our population is likely skewed towards patients with active epilepsy requiring regular clinic visits and who have a higher chance of being captured in this time-limited data collection period.
Our study has certain limitations because of its retrospective nature and the lack of a longitudinal follow-up to better characterize the outcome. The family history is particularly difficult to accurately quantify in a retrospective study, with a high risk of underreporting.
With the paucity of reliable sources describing the state of epilepsy in Qatar, we believe that our study is a major step to that end. In fact, because of similarities in population composition with neighboring countries, our study may be representative of the characteristics of epilepsy and its management in the whole Arabian Peninsula. Furthermore, despite the relatively small size of the country's population and the single health system source of the data, the rich mix of subjects of varied geographical backgrounds and socioeconomic states leads to significant heterogeneity in some epilepsy features, most notably regarding causes of epilepsy and treatment trends. Our population showed mixed features reported from both industrialized and developing countries, a trend that may become more common with population shifts and increasing immigration. Despite the fact that NCC is not endemic to Qatar, it has to be in the etiological differential diagnosis of PWE residing in Qatar but originating from countries in Southeast Asia, especially Nepal.
